Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa

被引:92
|
作者
Bailer, Ursula F.
Frank, Guido K.
Henry, Shannan E.
Price, Julie C.
Meltzer, Carolyn C.
Mathis, Chester A.
Wagner, Angela
Thornton, Laura
Hoge, Jessica
Ziolko, Scott K.
Becker, Carl R.
McConaha, Claire W.
Kaye, Walter H.
机构
[1] Univ Pittsburgh, Western Psychiat Inst & Clin, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA
[2] Med Univ Vienna, Dept Gen Psychiat, Univ Hosp Psychiat, Vienna, Austria
[3] Univ Pittsburgh, Presbyterian Univ Hosp, Sch Med, Dept Radiol, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Presbyterian Univ Hosp, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA
[5] Univ Calif San Diego, Sch Med, Dept Child & Adolescent Psychiat, San Diego, CA 92103 USA
[6] Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA
[7] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA
[8] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, D-6000 Frankfurt, Germany
基金
奥地利科学基金会;
关键词
anorexia nervosa; anxiety; 5-HT1A; 5-HT2A; positron emission tomography; serotonin;
D O I
10.1016/j.biopsych.2006.07.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Many studies have found disturbances of serotonin (5-HT) activity in anorexia nervosa (AN). Because little is known about 5-HT receptor function in AN, positron emission tomography (PET) imaging with 5-HT receptor-specific radioligands was used to characterize 5-HT1 A and 5-HT2A receptors. Methods: Fifteen women ill with AN (ILL AN) were compared with 29 healthy control women (CW); PET and [11C]WAY100635 were used to assess binding potential (BP) of the 5-HT1A receptor, and [18F]altanserin was used to assess postsynaptic 5-HT2A receptor BP. [150] water and PET were used to assess cerebral blood flow. Results: The ILL AN women had a highly significant (30%-70%) increase in [11C]WAY100635 BP in prefrontal and lateral orbital frontal regions, mesial and lateral temporal lobes, parietal cortex, and dorsal raphe nuclei compared with CW. The [18F]altanserin BP was normal in ILL AN but was positively and significantly related to harm avoidance in suprapragenual cingulate, frontal, and parietal regions. Cerebral blood flow was normal in ILL AN women. Conclusions: Increased activity of 5-HT1 A receptor activity may help explain poor response to 5-HT medication in ILL AN. This study extends data suggesting that 5-HT function, and, specifically, the 5-HT2A receptor, is related to anxiety in AN.
引用
收藏
页码:1090 / 1099
页数:10
相关论文
共 50 条
  • [41] Novel, flexible, and conformationally defined analogs of gepirone:: synthesis and 5-HT1A,5-HT2A, and D2 receptor activity
    Paluchowska, MH
    Bugno, R
    Bojarski, AJ
    Charakchieva-Minol, S
    Duszynska, B
    Tatarczynska, E
    Klodzinska, A
    Stachowicz, K
    Chojnacka-Wójcik, E
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) : 1195 - 1200
  • [42] Head twitches in serotonin transporter (SERT)-deficient mice:: 5-HT1A and 5-HT2A receptor interactions
    Fox, M. A.
    Stein, A. R.
    French, H. T.
    Murphy, D. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 91 - 91
  • [43] Effects of 5-HT1A and 5-HT2A receptor stimulation on performance on the fixed-interval peak procedure
    Asgari, K
    Body, S
    Zhang, Z
    Fone, KCF
    Bradshaw, CM
    Szabadi, E
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A40 - A40
  • [44] 5-HT1A and 5-HT2A ligands with anxiolytic and antipanic-like properties
    Diouf, O
    Carato, P
    Depreux, P
    Bonte, JP
    Caignard, DH
    GuardiolaLemaitre, B
    Rettori, MC
    Belzung, C
    Lesieur, D
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (20) : 2579 - 2584
  • [45] Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo
    Zhang, YH
    Gray, TS
    D'Souza, DN
    Carrasco, GA
    Damjanoska, KJ
    Dudas, B
    Garcia, F
    Zainelli, GM
    Hanley, NRS
    Battaglia, G
    Muma, NA
    Van de Kar, LD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01): : 59 - 66
  • [46] Arylpiperazine derivatives of 3-propyl-β-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands
    Byrtus, H
    Pawlowski, M
    Duszynska, B
    Wesolowska, A
    Chojnacka-Wójcik, E
    Bojarski, AJ
    POLISH JOURNAL OF PHARMACOLOGY, 2001, 53 (04): : 395 - 401
  • [47] Distribution of 5-HT1A and 5-HT2A receptor mRNA in various regions of the human brain and in resting lymphocytes
    Pasqualetti, M.
    Nardi, I.
    Cassano, G. B.
    Marazziti, D.
    BEHAVIOURAL PHARMACOLOGY, 1995, 6 : 120 - 121
  • [48] REPEATED ECS DIFFERENTIALLY AFFECTS RAT-BRAIN 5-HT1A AND 5-HT2A RECEPTOR EXPRESSION
    BURNET, PWJ
    MEAD, A
    EASTWOOD, SL
    LACEY, K
    HARRISON, PJ
    SHARP, T
    NEUROREPORT, 1995, 6 (06) : 901 - 904
  • [49] Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide
    Boger, DL
    Patterson, JE
    Jin, Q
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4102 - 4107
  • [50] Lack of association between neuroleptic malignant syndrome and polymorphisms in the 5-HT1A and 5-HT2A receptor genes
    Kawanishi, C
    Hanihara, T
    Shimoda, Y
    Suzuki, K
    Sugiyama, N
    Onishi, H
    Miyakawa, T
    Yamada, Y
    Kosaka, K
    AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (09): : 1275 - 1277